lecture 6c Flashcards
(90 cards)
what is included in drug formulation to manufacturing
stages that occur to get from a lead compound to it being manufactured and used by consumers.
when do drug formulation studies occur
thoughout the whole process
from preclinical studies to launch!!
what must be known before drug formulation
the drugs intended use must be known in order to be optimised!!
we must know it’s use before preclinical studies
examples of drug administration routes
oral dose
nasal spray
injection
what differs between drugs that are administered differently
their formulation differs.
they will be formulated differently in order to be optimised for their intended use
is the drug the main part of medicine
no!!
there are excipients in the medicine aswell!!
what 3 factors control bioavailability ‘F’
- the drugs rate and extent of release from its dosage form
- absorption from solution state
- bio transformation during absorption
what does the shape of a plasma conc profile depend on
relative rates of absorption and elimination
what do plasma conc profiles vary between
they vary depending on the route of administration
what administration leads to an early peak due to fast absorption on a plasma conc profile
intravenous
intramuscular
what administration route leads to a delayed peak on a plasma conc profile
oral, rectal, subcutaneous
is the rate of elimination constant
yes!
it depends on the nature of the active ingredient
3 things that make up drug disposition
distribution
metabolism
excretion
a drugs disposition is itsssss
ADME!!
absorption
adsorption
metabolism
extraction / elimination
plasma conc profile for multiple doses
furry graph
conc changes up and down with time
plasma conc profile for single dose
normal graph
increases, peak, decreases
conc increases then decreases with time
what are the visible phases of a plasma conc profile
absorption phase
elimination phase
what is Css
steady state concentration
when the absorption of the drug is equal to the elimination of the drug
what happens to the drug when it is administered using multiple doses
- drug accumulates in the body until plateau is reached
what happens when the plasma conc is too high for multiple doses
excessive adverse side effects occur
conc increases too high too fast
in multiple doses, where do we want the drug conc to be at
the therapeutic window.
the conc where effects are seen but there are no excessive side effects.
plasma drug conc increases slowly + therapeutic success is seen
areas of preformulation research
aka things we think about before formulating the drug
- physiochemical properties
- bulk characterisation
- solubility analysis
- stability analysis
preformulation research: physiochemical properties
physical properties
PURITY
SURFACE AREA
PARTICLE SIZE
PARTICLE SHAPE
preformulation research : bulk characterisation
powder flow properties
bulk density